How do you value a pre-revenue startup?

Pre-revenue startup valuation is less about spreadsheets and more about narrative, market size, and the credibility of the team. Investors are essentially pricing the probability that this specific group of people can capture a large market—before any proof exists. Understanding that dynamic lets you negotiate from clarity rather than anxiety.

What investors are actually pricing

When no revenue exists, a valuation is a bet on future outcomes, not a discounted cash flow calculation. Paul Graham's observation about startup investing—that effectively all returns concentrate in a handful of massive winners—explains why pre-revenue pricing feels so arbitrary. If a fund's entire return profile hinges on one or two breakout companies per cohort, investors aren't trying to find a 'fair' price for your current state; they're trying to decide whether you're the kind of outlier worth owning at any reasonable price.

This means the factors that drive pre-revenue valuation are almost entirely qualitative: the size of the market you're attacking, whether the problem is real and urgent, and whether the founders have an unfair advantage in solving it. A team with deep domain expertise, proprietary data, or an existing distribution channel commands a higher valuation than an equally early-stage team without those assets—even at zero revenue.

The practical implication: if you walk into a pre-revenue conversation leading with your financial model, you're playing the wrong game. Investors are pattern-matching against exceptional founders who've identified a non-obvious insight about a large market. Lead with that story.

The mechanics investors actually use

In the absence of revenue, investors lean on a handful of loose frameworks. Comparable deals—what similar-stage companies in your space raised at recently—establish a baseline. Accelerator demo days create reference points across hundreds of companies simultaneously, which is one reason the post-YC batch valuation range has become a de facto market price for a certain type of early-stage startup.

Beyond comps, investors apply a rough factor model: market size (TAM), team quality, technical differentiation, and traction signals that aren't revenue—things like waitlist size, pilot agreements, letters of intent, or user engagement metrics. Each of these is a proxy for the probability that this company becomes a large winner. The more proxies you can show, the more you shift the negotiation in your favor.

Another common approach is the 'risk-adjusted milestone' method: what would this company need to demonstrate to raise a Series A at a given valuation, and how likely are they to get there with this seed round? Seed investors are essentially pricing the probability-weighted value of that future milestone. If your go-to-market is plausible and your team is credible, you can sometimes anchor a valuation by showing what hitting specific metrics would make you worth—and working backward from there.

How founders should approach the valuation conversation

Paul Graham's advice on valuation is counterintuitively useful here: don't lead with a number, and don't treat valuation as the most important variable in the conversation. The priority is finding an investor who genuinely wants to partner with you. Once that alignment exists, price becomes a negotiation between two parties who both want the deal to happen—which is a much easier conversation than convincing a skeptical investor that your chosen number is justified.

This matters especially at the pre-revenue stage because valuation sensitivity early on can create downstream problems. A cap set artificially low because you capitulated to a tough negotiator will haunt you through every subsequent priced round—future investors will anchor to that number. Conversely, an inflated valuation because you got caught up in a competitive process can make your Series A nearly impossible if growth doesn't match the implied trajectory.

The practical move: enter conversations with a range, not a fixed number. Prioritize getting a committed investor to move first, then use that commitment to attract others. The first check is the hardest to get and the most valuable—not just for the capital, but because it sets the social proof that accelerates subsequent closes.

What actually moves the number in your favor

The single biggest lever on pre-revenue valuation is competitive pressure among investors. A company that multiple investors want to fund at the same time will command a higher valuation than an identical company that's fundraising sequentially without urgency. This is why the conventional advice to run a tight, time-boxed fundraising process exists—it's not theater, it's mechanism design.

Beyond process, the things that concretely move your valuation higher are: evidence that your problem is urgent and widespread (user interviews, survey data, industry reports), a technical or distribution moat that's hard to replicate (proprietary model weights, exclusive data partnerships, a network effect already forming), and a credible path to a specific, large market. The bigger and more defensible the opportunity looks, the higher the ceiling investors will accept.

One underrated factor is the quality of your existing investors or advisors. A pre-revenue company with a well-known angel or a strong institutional seed fund behind it raises at a higher valuation than one without—because that signal reduces perceived risk for the next investor in. If you're pre-raise, cultivating two or three credible advisors with relevant domain expertise is one of the cheapest ways to improve your valuation before you start the process.

The trap: optimizing valuation over everything else

Founders who treat early valuation as a scoreboard often create problems they don't see for 18 months. The real cost of a high pre-revenue valuation isn't dilution (which is low by definition when you're raising a small check at a high price)—it's the growth rate you're implicitly committing to. A $15M seed cap implies a trajectory; if you haven't hit the milestones that justify a $40-60M Series A lead valuation by the time you're back out fundraising, you face a flat or down round, which is far more damaging to morale and cap table than a modest seed valuation would have been.

Paul Graham's framing of fundraising phases is instructive here: the first check is buying the right to run the experiment. The next round requires the experiment to have worked. That's a completely different evidential bar—and many founders who raise exuberantly at the seed stage fail to appreciate how much harder the Series A becomes if they haven't used that time to generate the kind of traction that proves the experiment is working.

The right optimization target for pre-revenue valuation is: high enough to limit dilution on a check that lets you reach a meaningful milestone, low enough that you can defensibly show progress by the time you raise again. That's a narrower range than most founders realize, and finding it requires honesty about what you can actually accomplish in 18-24 months with the capital you're raising.

“The best ideas look initially like bad ideas.”

— Paul Graham, source

The one thing to do

Set your pre-revenue valuation based on what milestone the round funds and what that milestone needs to be worth to raise the next round—not on how much you can negotiate out of the first investor who says yes.

Frequently asked questions

Is there a standard valuation range for pre-revenue startups?

There's no universal standard, but post-accelerator seed rounds have created informal market norms in certain geographies and sectors. The real range depends on team strength, market size, and competitive investor interest—not a formula.

Should I use a SAFE or priced round at the pre-revenue stage?

Most pre-revenue companies use a SAFE or convertible note precisely because it defers the valuation question to a future priced round when there's more data. A valuation cap on a SAFE sets an upper bound on the conversion price, giving investors downside protection without requiring full price discovery today.

How do I justify a valuation with no revenue or users?

Justify it with the quality of the insight, the size of the market, the credibility of the team, and any non-revenue traction signals you have. You're not justifying a current price—you're making a case for what this company is likely to be worth if the bet pays off.

Does a high valuation hurt my chances of raising a Series A?

Yes, if you don't grow into it. Series A investors benchmark against your seed valuation and expect a step-up that reflects real progress. An inflated seed valuation without matching traction makes the math work against you.

Sources

More playbook answers · Growth Prophet home